James F. Dropinski

2.1k total citations
20 papers, 1.7k citations indexed

About

James F. Dropinski is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, James F. Dropinski has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in James F. Dropinski's work include Antifungal resistance and susceptibility (4 papers), Adipose Tissue and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). James F. Dropinski is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Adipose Tissue and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). James F. Dropinski collaborates with scholars based in United States and Czechia. James F. Dropinski's co-authors include James M. Balkovec, George K. Abruzzo, F. Aileen Bouffard, Daniel A. DiRocco, Ian W. Davies, Amy Flattery, Christopher Gill, L. Kong, Jeffrey G. Smith and H Kropp and has published in prestigious journals such as Science, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

James F. Dropinski

20 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James F. Dropinski United States 19 776 596 553 369 218 20 1.7k
Vladimı́r Buchta Czechia 26 399 0.5× 1.1k 1.9× 279 0.5× 544 1.5× 151 0.7× 96 2.0k
Tatiana Y. Hargrove United States 22 408 0.5× 732 1.2× 747 1.4× 493 1.3× 228 1.0× 35 1.7k
Michio Kurosu United States 26 358 0.5× 1.0k 1.7× 200 0.4× 1.0k 2.8× 363 1.7× 85 2.1k
Amir Azam India 30 329 0.4× 1.4k 2.4× 200 0.4× 428 1.2× 113 0.5× 75 2.3k
Prabagaran Narayanasamy United States 25 380 0.5× 1.1k 1.8× 257 0.5× 831 2.3× 124 0.6× 56 2.3k
Bruno J. Neves Brazil 20 171 0.2× 579 1.0× 202 0.4× 607 1.6× 185 0.8× 73 1.7k
Giovanna Poce Italy 24 634 0.8× 745 1.3× 421 0.8× 652 1.8× 210 1.0× 54 1.7k
Prithwiraj De India 16 198 0.3× 463 0.8× 164 0.3× 295 0.8× 80 0.4× 44 1.1k
Baojie Wan United States 34 1.0k 1.3× 2.1k 3.5× 535 1.0× 1.4k 3.8× 252 1.2× 86 3.3k
Martin Schlitzer Germany 23 253 0.3× 774 1.3× 145 0.3× 925 2.5× 272 1.2× 119 2.1k

Countries citing papers authored by James F. Dropinski

Since Specialization
Citations

This map shows the geographic impact of James F. Dropinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Dropinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Dropinski more than expected).

Fields of papers citing papers by James F. Dropinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Dropinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Dropinski. The network helps show where James F. Dropinski may publish in the future.

Co-authorship network of co-authors of James F. Dropinski

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Dropinski. A scholar is included among the top collaborators of James F. Dropinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Dropinski. James F. Dropinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuster, Christopher H., James F. Dropinski, Michael Shevlin, Hongming Li, & Song Chen. (2020). Ruthenium-Catalyzed Enantioselective Hydrogenation of Hydrazones. Organic Letters. 22(19). 7562–7566. 18 indexed citations
2.
DiRocco, Daniel A., Yining Ji, Edward C. Sherer, et al.. (2017). A multifunctional catalyst that stereoselectively assembles prodrugs. Science. 356(6336). 426–430. 137 indexed citations
3.
Schultz, Danielle M., François Lévesque, Daniel A. DiRocco, et al.. (2017). Oxyfunctionalization of the Remote C−H Bonds of Aliphatic Amines by Decatungstate Photocatalysis. Angewandte Chemie. 129(48). 15476–15480. 27 indexed citations
4.
Feng, Danqing, Tesfaye Biftu, F. Anthony Romero, et al.. (2017). Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase. ACS Medicinal Chemistry Letters. 9(1). 39–44. 42 indexed citations
5.
Schultz, Danielle M., François Lévesque, Daniel A. DiRocco, et al.. (2017). Oxyfunctionalization of the Remote C−H Bonds of Aliphatic Amines by Decatungstate Photocatalysis. Angewandte Chemie International Edition. 56(48). 15274–15278. 138 indexed citations
6.
Kutchukian, Peter S., James F. Dropinski, Kevin D. Dykstra, et al.. (2016). Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods. Chemical Science. 7(4). 2604–2613. 187 indexed citations
7.
Xu, Libo, James F. Dropinski, Peter T. Meinke, et al.. (2012). Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs. Bioorganic & Medicinal Chemistry Letters. 23(1). 366–369. 19 indexed citations
8.
Xu, Libo, James F. Dropinski, Peter T. Meinke, et al.. (2009). Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides. Bioorganic & Medicinal Chemistry Letters. 19(13). 3531–3535. 28 indexed citations
9.
Dropinski, James F., Taro E. Akiyama, Monica Einstein, et al.. (2005). Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5035–5038. 56 indexed citations
10.
Liu, Weiguo, James F. Dropinski, Lawrence F. Colwell, et al.. (2005). Design, synthesis, and structure–activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis. Bioorganic & Medicinal Chemistry Letters. 15(20). 4574–4578. 23 indexed citations
11.
Dropinski, James F., Yong Zhang, Conrad Santini, et al.. (2005). Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids:  Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity. Journal of Medicinal Chemistry. 48(17). 5589–5599. 87 indexed citations
12.
Dropinski, James F., Brian M. McKeever, Shihua Xu, et al.. (2005). Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives:  A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity. Journal of Medicinal Chemistry. 48(13). 4457–4468. 66 indexed citations
13.
Powles, Mary Ann, Paul Liberator, Jennifer Anderson, et al.. (1998). Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii. Antimicrobial Agents and Chemotherapy. 42(8). 1985–1989. 108 indexed citations
14.
Gill, Christopher, George K. Abruzzo, Amy Flattery, et al.. (1997). In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy. 41(11). 2326–2332. 262 indexed citations
15.
Hajdu, Richard, Jon G. Sundelof, Barbara A. Pelak, et al.. (1997). Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy. 41(11). 2339–2344. 141 indexed citations
16.
Abruzzo, George K., Amy Flattery, Christopher Gill, et al.. (1997). Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and Chemotherapy. 41(11). 2333–2338. 204 indexed citations
17.
Kurtz, Martha, E M Bernard, F F Edwards, et al.. (1995). Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy. 39(8). 1784–1789. 44 indexed citations
18.
Schmatz, Dennis M., Maryann Powles, K Nollstadt, et al.. (1995). New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrobial Agents and Chemotherapy. 39(6). 1320–1323. 38 indexed citations
19.
Bouffard, F. Aileen, Robert A. Zambias, James F. Dropinski, et al.. (1994). Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives. Journal of Medicinal Chemistry. 37(2). 222–225. 94 indexed citations
20.
Bouffard, F. Aileen, Robert A. Zambias, James F. Dropinski, et al.. (1994). ChemInform Abstract: Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives.. ChemInform. 25(20). 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026